Improving blood sugar control in pregnant women with diabetes receiving corticosteroids
Close the GAP: Glycemic control after Antenatal corticosteroids in women with Pregestational diabetes
This study is looking at how a common treatment for preterm birth affects blood sugar levels in pregnant women with type 2 diabetes, and it aims to find the best ways to keep their blood sugar stable to help ensure healthier outcomes for their babies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10993193 on NIH RePORTER |
What this research studies
This research investigates how antenatal corticosteroids affect blood sugar levels in pregnant women with type 2 diabetes who are at risk of preterm birth. It aims to optimize maternal glycemic control after these corticosteroid treatments using continuous glucose monitoring. By comparing different treatment strategies, the study seeks to understand how maternal blood sugar levels influence neonatal outcomes. This approach addresses a significant gap in existing research, as previous studies have not included women with diabetes.
Who could benefit from this research
Good fit: Ideal candidates for this research are pregnant women diagnosed with type 2 diabetes who are at risk of preterm birth and may require antenatal corticosteroid treatment.
Not a fit: Patients who are not pregnant or do not have type 2 diabetes may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better management of blood sugar levels in pregnant women with diabetes, improving health outcomes for both mothers and their babies.
How similar studies have performed: While there have been numerous studies on antenatal corticosteroids, this research is novel as it specifically focuses on women with type 2 diabetes, a population that has been largely overlooked in previous trials.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Battarbee, Ashley Nicole — University of Alabama at Birmingham
- Study coordinator: Battarbee, Ashley Nicole
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.